glp 1 and migraine GLP-1 drugs used for diabetes may slash frequency by half GLP-1 Receptor Agonists have an

Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ, et al: A glucagon-like Peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity

Switching within class or to a dualincretin agent may help some, but others never recapture early momentum

Efficacy and tolerability of vildagliptin monotherapy in drug-nave patients with type 2 diabetes

In adults with overweight or obesity and prediabetes, the treatment plan should prioritize obesity medications with demonstrated evidence for preventing progression to type 2 diabetes

That shifts the market toward brands that can prove formulation relevance and repeat-use practicality instead of simply adding GLP-1 language to standard nutrition products